期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

英夫利西单抗治疗关节病性银屑病进展 被引量：3

原文传递
导出
摘要 关节病性银屑病（PsA）可累及四肢、脊柱等单个或多个关节，是一种慢性炎症过程。70％～85％患者在关节症状出现前有过皮损。约25％。34％银屑病患者并发关节症状。PsA具有较大侵蚀性，严重时可使关节畸形，甚至使患者丧失基本活动能力，具有难治性特点。
作者 余晓玲 晋红中
机构地区 中国医学科学院北京协和医学院北京协和医院皮肤科
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2014年第3期223-225,共3页 Chinese Journal of Dermatology
基金 北京市自然科学基金（7103175）
关键词 关节病性银屑病 单抗治疗 英夫利西 银屑病患者 关节症状 炎症过程 关节畸形 活动能力
分类号 R758.63 [医药卫生—皮肤病学与性病学]
  • 相关文献

参考文献17

  • 1Vilma VS,de Carvalho JF,de Moraes JC. Autoantibodies in patients with psoriatic arthritis on anti-TNFa therapy[J].Revista Brasileira de Reumatologia,2010,(03):225-234.
  • 2Antoni CE,Kavanaugh A,Kirkham B. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis[J].Arthritis and Rheumatism,2005,(04):1227-1236.
  • 3Antoni CE,Kavanaugh A,Van der Heijde D. Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis:findings of the infliximab multinational psoriatic arthritis controlled trial (IMPACT)[J].Journal of Rheumatology,2008,(05):869-876.
  • 4Smolen JS,Emery P. Infliximab:12 years of experience[J].Arthritis Research and Therapy,2011,(Suppl 1):1-18.
  • 5Voulgari PV,Venetsanopoulou AI,Exarchou SA. Sustained clinical response and high infliximab survival in psoriatic arthritis patients:a 3-year long-term study[J].Seminars in Arthritis and Rheumatism,2008,(05):293-298.
  • 6Di Renzo L,Saraceno R,Schipani C. Why 3 mg/kg instead of 5 mg/kg of infliximab should work in psoriatic arthritis[J].Journal of Dermatology,2009,(12):666-668.
  • 7Alstergren P,Larsson PT,Kopp S. Successful treatment with multiple intra-articular injections of infliximab in a patient with psoriatic arthritis[J].Scandinavian Journal of Rheumatology,2008,(02):155-157.
  • 8Conti F,Ceccarelli F,Priori R. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids.Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha[J].Annals of the Rheumatic Diseases,2008,(12):1787-1790.
  • 9Antoni C,Krueger GG,de Vlam K. Infliximab improves signs and symptoms of psoriatic arthritis:results of the IMPACT 2 trial[J].Annals of the Rheumatic Diseases,2005,(08):1150-1157.
  • 10Saad AA,Ashcroft DM,Watson KD. Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor[J].Therapies Arthritis Care Res,2010,(03):345-353.

同被引文献42

  • 1李世泰,俞宝田,谢勇,冯景春,李红春,王宝明,方凯,王玉琪,闫岩.PUVA/UVB治疗银屑病60例疗效观察[J].中华皮肤科杂志,1996,29(2):128-129. 被引量：9
  • 2晋红中,王宝玺,甘戈,谢勇,刘跃华,何志新.骨化三醇软膏治疗慢性轻中度斑块型银屑病的随机单盲对照临床试验[J].中国临床药理学杂志,2006,22(2):95-99. 被引量：4
  • 3Papp K.A.,Bressinck R.,Fretzin S.,李政霄.依法利珠单抗治疗慢性中重度斑块型银屑病的安全性:一项IIIb期、随机、对照临床试验[J].世界核心医学期刊文摘（皮肤病学分册）,2006,2(8):39-40. 被引量：1
  • 4张胜正,刘跃华,徐景娜.关节病性银屑病并发葡萄膜炎[J].临床皮肤科杂志,2007,36(1):30-31. 被引量：2
  • 5Gottlieb AB, Chamian F, Masud S, et down-regulates muhiple proinflammatow pathways in psoriasis plaques [ J. ] Immunol, 2005, 175 (4): 2721-2729. DOI: l 0.4049/ jimmunol. 175.4.2721.
  • 6Kimber 1, Cumberbatch M, Dearman RJ, et al. Cytokines and chenmkines in the initiation anti regulation of epidermal Langerhans cell mobilization [J ]. Br J Demlatol. 2000, 142 ( 3 ): 401-412. DOI: 10.1046/j.1365-2133.2000.03349.x.
  • 7Langley RG, Strober BE, Gu Y, et al. Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis [J ]. Br J Dermatol, 2010, 162 (6): 1349-1358. DOI: 10.1111/j.1365- 2133.2010.09707.x.
  • 8Ahmad K, Rogers S. Three years' experience with infliximab in recalcitrant psoriasis[J]. Clin Exp Dermatol, 2006, 31 ( 5 ): 630- 633. DOI: 10.111 l/j.1365-2230.2006.02170.x.
  • 9Warren RB, Brown BC, Lavery D, et al. Biologic therapies for psoriasis: practical experience in a U.K. tertiary referr',d centre [J ]. Br J Dennatol, 2009, 160 (1): 162-169. DOI: 10.1111/j.1365- 2133.2008.08865.x.
  • 10Menter A, Feldman SR, Weinstein GD, et al. A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis[J]. J Am Aead Dermatol, 2007, 56( 1 ): 31. DOI: 10.1016/ j.jaad.2006.07.017.

引证文献3

二级引证文献24

中华皮肤科杂志
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部